Supplementary Materials

Supplemental Methods
IC50 (nM)
Human (Gottowik et al., 1993) Rat (Da Prada et al., 1990; Da Prada et al., 1989) Table 2 . List of binding sites tested. Sembragiline was tested at concentration 10 μM. (h) indicates where the human receptor or enzyme was used. Selectivity screen was performed at Cerep, France according to their standard operating procedures (see www.cerep.com; for details).
Quantification of PEA, spermine and spermidine
Analyte brain content was determined by HPLC with tandem mass spectrometry detection, using as internal standards D4-phenylethylamine for PEA, D3-spermine (deuterated) spermine and none for spermidine. An aliquot of 25 μL of each experimental sample was mixed with 4 μL of internal standard solution. The resulting mixture was automatically derivatised with 20 μL SymDAQ™ (within an auto-sampler). After two minutes, 40 μL of the mixture was injected into the liquid chromatography (LC) system by an automated sample injector (SIL-20AD, Shimadzu, Japan).
Chromatographic separation was performed on a Polaris C18 column (150 x 2 mm, particle size 3 μm) held at a temperature of 30°C in a gradient elution run, using eluent A (formic acid 0.1% v/v in ultrapurified H2O) and eluent B (formic acid 0.1% v/v in acetonitrile). The flow (total flow: 0.25 mL/min) of the LC was diverted to waste for 4 minutes, after which it was switched to the mass spectrometer (MS) for detection of the analytes and internal standards. A post-column make-up flow of acetonitrile + 1.0% formic acid (0.10 mL/min) was added to the column effluent to enhance ionisation efficiency. MS analyses were performed using an API 5000 MS/MS system consisting of an API 5000 MS/MS analyser and a Turbo Ion Spray interface (both from Applied Biosystems, USA).
The acquisitions were performed in positive ionisation mode, with ionisation spray voltage set at 5.5 kV and a probe temperature of 600 °C. The instrument was operated in multiple-reaction-monitoring (MRM) mode. Calibration curves ranging 0.05-100 nM for PEA, 1-2000 nM for spermine and 0.005-10.0 μM for spermidine were fitted using weighted (1/x) regression, and the sample concentrations were determined using these calibration curves. Accuracy was verified by quality control samples after each sample series. Concentrations were calculated with the Analyst™ data system (version 1.5.2, Applied Biosystems, the Netherlands). Table 3 : After L-5-HTP injection, rats were monitored for the occurrence of the specific behaviours of interest indicated above for 1 hour. Total frequency of all the individual behaviours was added into two compound scores represented by the "5-HT Syndrome" and the "Other behaviour" clustering.
Supplemental Results
Supplemental Figure 1 . Time-course of MAO-A and MAO-B inhibition in the rat brain after oral administration of 0.3 mg/kg sembragiline once a day for 5 days. Mean ±SD, n=3.
Supplemental Figure 2.
The effect of sembragiline on astrogliosis in the hippocampus. MAO-B mice with and without induction of MAO-B overexpression were treated with 3 mg/kg oral sembragiline or vehicle daily for 14 days. Quantification of GFAP+ hippocampal cell count.
***
